Source comparison
MK-677 Dosing Comparison: Recovery Contexts
Acute soft tissue injury (tendon, ligament, muscle strain) 10–12.5mg daily 20mg daily 12–16 weeks 40–60% above baseline Weekly glucose, subjective pain scores Aligns with collagen synthesis and remodeling timelines. Most cost-effective for single-injury recove
This comparison does not assign a generated winner or score.
- Acute soft tissue injury (tendon, ligament, muscle strain)
- 10–12.5mg daily
- 20mg daily
- 12–16 weeks
- 40–60% above baseline
- Weekly glucose, subjective pain scores
- Aligns with collagen synthesis and remodeling timelines. Most cost-effective for single-injury recovery
- Post-surgical recovery (orthopedic procedures)
- 12.5–15mg daily
- 20–25mg daily
- 16–20 weeks
- 50–70% above baseline
- Fasting glucose, inflammatory markers (CRP)
- Extended cycle justified by surgical tissue trauma. Coordinate with surgical team
- Chronic joint/cartilage degradation
- 12.5mg daily
- 24–36 weeks
- 50–80% above baseline
- HbA1c every 8 weeks, joint range-of-motion assessments
- Long-term use magnifies metabolic monitoring requirements but produces measurable cartilage health improvements
- Age-related recovery decline (40+ years)
- 10mg daily
- 15–20mg daily
- 24+ weeks continuous or cycled
- 35–55% above baseline
- Bone density (DEXA), fasting insulin, lipid panel
- Lower doses sufficient in older populations. Prioritize glucose control over maximum IGF-1 elevation
- Athletic performance recovery (training volume)
- 15mg daily
- 12–16 weeks during high-volume phases
- Sleep quality, subjective recovery scores, glucose
- Higher doses tolerated in metabolically healthy athletes. Taper before competition if drug testing applies